Video
Why Treatment Fails: Interferons, Immune Rewiring, and Biological Escape Mechanisms.
Professor Curdin Conrad discusses why psoriasis treatments may fail, drawing on immunological mechanisms and relevant…
Professor Curdin Conrad discusses why psoriasis treatments may fail, drawing on immunological mechanisms and relevant…
Watch VideoIPC summarizes presentations from its symposium at the 2026 SID Annual Meeting, including disease interception,…
View ReportIPC Councilor Curdin Conrad reviews conventional oral systemic therapies, including their proper use and recent…
Watch VideoThe 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
View ReportProfessor Curdin Conrad discusses trained immunity and epigenetic memory in inflammatory diseases, highlighting…
Watch VideoThe 2024 IPC Think Tank Congress Report provides a comprehensive summary of key topics, including the epidemiology of…
Read MoreThe program chair and faculty address questions from IPC Global Webinar 3: "The Full Cycle of Psoriasis Care in 2024:…
Watch VideoDr. Curdin Conrad explores guttate psoriasis and discusses various treatment options and therapies designed to target…
Watch VideoIPC GLOBAL WEBINAR SERIES Program chairs: Curdin Conrad, Switzerland Program faculty: Cristina Echeverría, Argentina…
The 2024 Society for Investigative Dermatology (SID) Annual Meeting was held from May 14 to 18, 2024, in Dallas, Texas,…
Read MoreDr. Curdin Conrad offers insights into the latest advances in psoriasis treatment, highlighting the factors that…
Watch VideoSOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID) | DALLAS, TEXAS Wednesday, May 15 9:00 - 12:00 CDT Program chairs:…
Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in…
Read MoreDr. Conrad discusses whether we can now modify the course of the disease or at least prevent the need for ongoing…
Watch VideoThe International Society of Investigative Dermatology (ISID) held its inaugural meeting in Tokyo, Japan, from May 10…
Read MoreThe European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…
Read MoreINTERNATIONAL SOCIETIES FOR INVESTIGATIVE DERMATOLOGY MEETING (ISID) | TOKYO, JAPAN Wednesday, May 10 11:30 - 15:00…
The Psoriasis: from Gene to Clinic International Congress provides a forum for psoriasis experts from around the world…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
A new IPC paper in JAAD presents five priorities for improving metabolic screening, advancing GLP-1 research in the context of psoriasis, and defining the dermatologist’s role in managing cardiometabolic risk in psoriasis patients.
IPC Jr. Councilor Mio Nakamura speaks with Dr. John Koo about how personality traits, including borderline personality disorder, shape clinical interactions and shares practical strategies for dermatologists to build stronger patient relationships.
Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.
The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.
Rare ADAR1 gene mutations drive a distinct, interferon-fueled psoriasis subtype, and it responds to JAK1 and TYK2 inhibitors rather than standard IL-17/IL-23 biologics.
IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.
IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.